|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.979
|
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.977
|
|
|
|
positive regulation of triglyceride metabolic process
|
GO:0090208 |
9 |
0.966
|
|
|
|
triglyceride catabolic process
|
GO:0019433 |
9 |
0.956
|
|
|
|
glycerolipid catabolic process
|
GO:0046503 |
16 |
0.945
|
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.939
|
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.931
|
|
|
|
positive regulation of lipoprotein lipase activity
|
GO:0051006 |
3 |
0.914
|
|
|
|
acylglycerol catabolic process
|
GO:0046464 |
11 |
0.905
|
|
|
|
regulation of lipid catabolic process
|
GO:0050994 |
15 |
0.902
|
|
|
|
positive regulation of triglyceride catabolic process
|
GO:0010898 |
3 |
0.888
|
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.884
|
|
|
|
regulation of triglyceride metabolic process
|
GO:0090207 |
17 |
0.859
|
|
|
|
positive regulation of triglyceride lipase activity
|
GO:0061365 |
3 |
0.832
|
|
|
|
regulation of lipoprotein lipase activity
|
GO:0051004 |
4 |
0.832
|
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.779
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.760
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.722
|
|
|
|
neutral lipid catabolic process
|
GO:0046461 |
11 |
0.673
|
|
|
|
cellular lipid catabolic process
|
GO:0044242 |
52 |
0.641
|
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.627
|
|
|
|
positive regulation of lipid catabolic process
|
GO:0050996 |
6 |
0.604
|
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.604
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.595
|
|
|
|
sequestering of triglyceride
|
GO:0030730 |
6 |
0.575
|
|
|
|
plasma lipoprotein particle clearance
|
GO:0034381 |
13 |
0.563
|
|
|
|
acylglycerol biosynthetic process
|
GO:0046463 |
18 |
0.553
|
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.511
|
|
|
|
regulation of triglyceride catabolic process
|
GO:0010896 |
5 |
0.486
|
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.454
|
|
|
|
glycerolipid biosynthetic process
|
GO:0045017 |
50 |
0.451
|
|
|
|
regulation of fatty acid oxidation
|
GO:0046320 |
10 |
0.394
|
|
|
|
triglyceride biosynthetic process
|
GO:0019432 |
17 |
0.346
|
|
|
|
response to ischemia
|
GO:0002931 |
14 |
0.333
|
|
|
|
vacuole organization
|
GO:0007033 |
38 |
0.331
|
|
|
|
negative regulation of lipid catabolic process
|
GO:0050995 |
6 |
0.310
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.301
|
|
|
|
regulation of glutamine family amino acid metabolic process
|
GO:0000820 |
1 |
0.295
|
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.294
|
|
|
|
regulation of sequestering of triglyceride
|
GO:0010889 |
6 |
0.290
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.286
|
|
|
|
regulation of phosphatidylcholine catabolic process
|
GO:0010899 |
2 |
0.284
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.283
|
Worm |
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.280
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.276
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.273
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.266
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.259
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.252
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.243
|
|
|
|
regulation of lipid storage
|
GO:0010883 |
20 |
0.240
|
|
|
|
lipid storage
|
GO:0019915 |
36 |
0.235
|
Worm |
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.231
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.226
|
|
|
|
cytoskeleton dependent intracellular transport
|
GO:0030705 |
50 |
0.212
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.212
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.210
|
|
|
|
cholesterol storage
|
GO:0010878 |
4 |
0.208
|
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.208
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.205
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.205
|
|
|
|
autophagy
|
GO:0006914 |
45 |
0.196
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.187
|
|
|
|
phospholipid catabolic process
|
GO:0009395 |
5 |
0.185
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.176
|
Worm |
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.175
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.174
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.169
|
Worm |
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.165
|
|
|
|
neutral lipid biosynthetic process
|
GO:0046460 |
18 |
0.156
|
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.155
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.153
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.151
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.151
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.141
|
|
|
|
single organism nuclear import
|
GO:1902593 |
95 |
0.139
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.138
|
|
|
|
lipid particle organization
|
GO:0034389 |
7 |
0.133
|
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.132
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.128
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.127
|
|
|
|
microtubule based movement
|
GO:0007018 |
84 |
0.121
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.120
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.120
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.119
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.118
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.114
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.112
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.111
|
|
|
|
negative regulation of lipid metabolic process
|
GO:0045833 |
30 |
0.110
|
|
|
|
positive regulation of lipid storage
|
GO:0010884 |
10 |
0.109
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.108
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.108
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.107
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.106
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.105
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.102
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.100
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.099
|
|
|
|
cellular response to increased oxygen levels
|
GO:0036295 |
1 |
0.097
|
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.091
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.091
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.091
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.091
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.088
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.088
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.084
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.084
|
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.083
|
|
|
|
glycerophospholipid metabolic process
|
GO:0006650 |
71 |
0.082
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.081
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.081
|
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.081
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.080
|
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.080
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.079
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
15 |
0.078
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.078
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.077
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
81 |
0.076
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.075
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.075
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.074
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.073
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.072
|
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.072
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.071
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.070
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.069
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.069
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
129 |
0.068
|
|
|
|
cellular response to starvation
|
GO:0009267 |
57 |
0.067
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.067
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.066
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.065
|
|
|
|
positive regulation of lipid biosynthetic process
|
GO:0046889 |
18 |
0.065
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.065
|
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.064
|
|
|
|
regulation of steroid metabolic process
|
GO:0019218 |
39 |
0.063
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.062
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.062
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.062
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.061
|
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.059
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.059
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.059
|
|
|
|
regulation of mitochondrial fission
|
GO:0090140 |
3 |
0.058
|
|
|
|
valine metabolic process
|
GO:0006573 |
4 |
0.058
|
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.058
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.057
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.057
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.057
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.056
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.056
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.056
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.056
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.056
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.056
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.055
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
64 |
0.055
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.054
|
|
|
|
negative regulation of sterol transport
|
GO:0032372 |
4 |
0.054
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.054
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.054
|
|
|
|
negative regulation of lipid storage
|
GO:0010888 |
6 |
0.053
|
|
|
|
negative regulation of sequestering of triglyceride
|
GO:0010891 |
2 |
0.053
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.053
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.053
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.053
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
133 |
0.052
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.052
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.052
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.051
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.051
|
|
|
|
regulation of p38mapk cascade
|
GO:1900744 |
3 |
0.050
|
|
|
|
plasma lipoprotein particle organization
|
GO:0071827 |
11 |
0.050
|
|
|
|
response to starvation
|
GO:0042594 |
65 |
0.049
|
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.049
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.049
|
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.049
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.048
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.048
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.047
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.047
|
Worm |
|
|
reverse cholesterol transport
|
GO:0043691 |
6 |
0.047
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.047
|
Worm |
|
|
ammonia assimilation cycle
|
GO:0019676 |
2 |
0.047
|
|
|
|
p38mapk cascade
|
GO:0038066 |
4 |
0.046
|
|
|
|
regulation of phospholipid catabolic process
|
GO:0060696 |
2 |
0.046
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.046
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.046
|
|
|
|
organic acid catabolic process
|
GO:0016054 |
51 |
0.046
|
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.046
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.046
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.046
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.045
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.045
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.045
|
|
|
|
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000161 |
1 |
0.045
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.044
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.044
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.043
|
|
|
|
response to hyperoxia
|
GO:0055093 |
2 |
0.043
|
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.043
|
|
|
|
positive regulation of cholesterol transport
|
GO:0032376 |
9 |
0.043
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.043
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.042
|
|
|
|
cellular response to prostaglandin stimulus
|
GO:0071379 |
2 |
0.042
|
|
|
|
regulation of triglyceride biosynthetic process
|
GO:0010866 |
10 |
0.042
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.042
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.041
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.041
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.041
|
|
|
|
positive regulation of phagocytosis engulfment
|
GO:0060100 |
3 |
0.041
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.040
|
|
|
|
negative regulation of reactive oxygen species biosynthetic process
|
GO:1903427 |
0 |
0.040
|
|
|
|
cell proliferation in hindbrain
|
GO:0021534 |
10 |
0.039
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.039
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.038
|
Worm |
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.038
|
|
|
|
glycerophospholipid catabolic process
|
GO:0046475 |
5 |
0.038
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.038
|
|
|
|
thioester biosynthetic process
|
GO:0035384 |
7 |
0.038
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.037
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.037
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.037
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.037
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.037
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.037
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.037
|
|
|
|
regulation of presynaptic membrane organization
|
GO:1901629 |
3 |
0.037
|
|
|
|
regulation of steroid biosynthetic process
|
GO:0050810 |
26 |
0.036
|
|
|
|
high density lipoprotein particle remodeling
|
GO:0034375 |
4 |
0.036
|
|
|
|
fatty acid beta oxidation
|
GO:0006635 |
16 |
0.036
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.036
|
|
|
|
muscle adaptation
|
GO:0043500 |
39 |
0.036
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
28 |
0.036
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.036
|
|
|
|
intracellular cholesterol transport
|
GO:0032367 |
3 |
0.036
|
|
|
|
low density lipoprotein particle clearance
|
GO:0034383 |
8 |
0.036
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.036
|
|
|
|
adiponectin activated signaling pathway
|
GO:0033211 |
4 |
0.036
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.035
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.035
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.035
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.035
|
|
|
|
cellular amino acid catabolic process
|
GO:0009063 |
25 |
0.035
|
|
|
|
negative regulation of tyrosine phosphorylation of stat5 protein
|
GO:0042524 |
2 |
0.035
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.035
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.035
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.035
|
|
|
|
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:2000162 |
1 |
0.034
|
|
|
|
glucose import
|
GO:0046323 |
32 |
0.034
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.033
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
65 |
0.033
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.033
|
|
|
|
vitamin d biosynthetic process
|
GO:0042368 |
3 |
0.033
|
|
|
|
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000148 |
1 |
0.033
|
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.033
|
|
|
|
response to low density lipoprotein particle
|
GO:0055098 |
2 |
0.033
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.033
|
Worm |
|
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.033
|
|
|
|
thioester metabolic process
|
GO:0035383 |
19 |
0.033
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.033
|
|
|
|
regulation of ammonia assimilation cycle
|
GO:2001248 |
1 |
0.033
|
|
|
|
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis
|
GO:2000166 |
1 |
0.032
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.032
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.032
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.032
|
|
|
|
mammary gland duct morphogenesis
|
GO:0060603 |
38 |
0.032
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.032
|
|
|
|
acetyl coa biosynthetic process
|
GO:0006085 |
5 |
0.032
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.032
|
|
|
|
monocarboxylic acid catabolic process
|
GO:0072329 |
27 |
0.031
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.031
|
|
|
|
regulation of removal of superoxide radicals
|
GO:2000121 |
4 |
0.031
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.031
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.031
|
|
|
|
regulation of cholesterol homeostasis
|
GO:2000188 |
9 |
0.031
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.031
|
|
|
|
regulation of urea metabolic process
|
GO:0034255 |
1 |
0.031
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.030
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.030
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.030
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.030
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.030
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.029
|
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.029
|
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.029
|
|
|
|
sensory perception of umami taste
|
GO:0050917 |
4 |
0.029
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.029
|
|
|
|
positive regulation of presynaptic membrane organization
|
GO:1901631 |
1 |
0.029
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.029
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.029
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.028
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.028
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.028
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.028
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.028
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.028
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.028
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.028
|
|
|
|
negative regulation of cholesterol transport
|
GO:0032375 |
4 |
0.028
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.028
|
|
|
|
positive regulation of creb transcription factor activity
|
GO:0032793 |
4 |
0.028
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.027
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.027
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.027
|
|
|
|
regulation of cholesterol transport
|
GO:0032374 |
17 |
0.027
|
|
|
|
cerebellum morphogenesis
|
GO:0021587 |
42 |
0.027
|
|
|
|
negative regulation of platelet derived growth factor receptor beta signaling pathway
|
GO:2000587 |
2 |
0.027
|
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.027
|
|
|
|
keratinocyte migration
|
GO:0051546 |
3 |
0.027
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.027
|
|
|
|
coenzyme biosynthetic process
|
GO:0009108 |
23 |
0.027
|
|
|
|
intracellular lipid transport
|
GO:0032365 |
3 |
0.027
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
88 |
0.027
|
|
|
|
cellular respiration
|
GO:0045333 |
38 |
0.026
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.026
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.026
|
|
|
|
regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000163 |
1 |
0.026
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.026
|
|
|
|
response to epidermal growth factor
|
GO:0070849 |
4 |
0.026
|
|
|
|
positive regulation of metalloenzyme activity
|
GO:0048554 |
3 |
0.026
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.026
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.026
|
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.026
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.026
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.026
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.026
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.025
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.025
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.025
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.025
|
|
|
|
sterol import
|
GO:0035376 |
2 |
0.025
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.025
|
Worm |
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.025
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.025
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.025
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.025
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.025
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.025
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.025
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.025
|
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.025
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.025
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.024
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.024
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.024
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.024
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
49 |
0.024
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.024
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.024
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.024
|
|
|
|
response to copper ion
|
GO:0046688 |
3 |
0.024
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.024
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.024
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.024
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.024
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.024
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.024
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.024
|
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.023
|
|
|
|
cellular response to arsenic containing substance
|
GO:0071243 |
4 |
0.023
|
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.023
|
|
|
|
positive regulation of bone remodeling
|
GO:0046852 |
13 |
0.023
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.023
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.023
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.023
|
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.023
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.023
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.023
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.023
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.023
|
|
|
|
reactive nitrogen species metabolic process
|
GO:2001057 |
0 |
0.023
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.023
|
|
|
|
beta amyloid clearance
|
GO:0097242 |
2 |
0.022
|
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.022
|
|
|
|
receptor mediated endocytosis of low density lipoprotein particle involved in cholesterol transport
|
GO:0090118 |
1 |
0.022
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.022
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.022
|
|
|
|
receptor biosynthetic process
|
GO:0032800 |
3 |
0.022
|
|
|
|
negative regulation of fat cell differentiation
|
GO:0045599 |
36 |
0.022
|
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.022
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.022
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.022
|
Worm |
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.022
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.022
|
|
|
|
positive regulation of protein catabolic process
|
GO:0045732 |
60 |
0.022
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
alcohol catabolic process
|
GO:0046164 |
16 |
0.021
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.021
|
|
|
|
positive regulation of macrophage derived foam cell differentiation
|
GO:0010744 |
4 |
0.021
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.021
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.021
|
|
|
|
bone development
|
GO:0060348 |
120 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
fatty acid catabolic process
|
GO:0009062 |
25 |
0.021
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.021
|
|
|
|
regulation of pinocytosis
|
GO:0048548 |
1 |
0.021
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.021
|
|
|
|
notochord cell development
|
GO:0060035 |
1 |
0.021
|
|
|
|
regulation of fatty acid beta oxidation
|
GO:0031998 |
1 |
0.021
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.021
|
|
|
|
glucan biosynthetic process
|
GO:0009250 |
14 |
0.021
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.021
|
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.021
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.020
|
|
|
|
cdc42 protein signal transduction
|
GO:0032488 |
0 |
0.020
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.020
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.020
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.020
|
|
|
|
positive regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903052 |
31 |
0.020
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.020
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.020
|
|
|
|
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:2000164 |
1 |
0.020
|
|
|
|
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:2000149 |
1 |
0.020
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.020
|
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.020
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
macromolecular complex remodeling
|
GO:0034367 |
6 |
0.020
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.020
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.020
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.020
|
|
|
|
glutamate metabolic process
|
GO:0006536 |
9 |
0.020
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.020
|
|
|
|
positive regulation of striated muscle cell differentiation
|
GO:0051155 |
35 |
0.020
|
|
|
|
establishment of mitochondrion localization
|
GO:0051654 |
4 |
0.020
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.020
|
|
|
|
positive regulation of fat cell differentiation
|
GO:0045600 |
32 |
0.020
|
|
|
|
body fluid secretion
|
GO:0007589 |
53 |
0.020
|
|
|
|
ribonucleotide biosynthetic process
|
GO:0009260 |
59 |
0.020
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.020
|
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.020
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.020
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.020
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.019
|
|
|
|
negative regulation of neuron projection development
|
GO:0010977 |
50 |
0.019
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.019
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.019
|
|
|
|
response to vitamin a
|
GO:0033189 |
1 |
0.019
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.019
|
|
|
|
regulation of cholesterol storage
|
GO:0010885 |
4 |
0.019
|
|
|
|
cerebellar granule cell precursor proliferation
|
GO:0021930 |
10 |
0.019
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.019
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.019
|
|
|
|
receptor mediated endocytosis
|
GO:0006898 |
51 |
0.019
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.019
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.019
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.019
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.019
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.019
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.019
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.019
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.019
|
|
|
|
positive regulation of steroid biosynthetic process
|
GO:0010893 |
4 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.019
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.019
|
|
|
|
response to oxygen radical
|
GO:0000305 |
16 |
0.019
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.019
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.019
|
|
|
|
organophosphate ester transport
|
GO:0015748 |
28 |
0.019
|
|
|
|
lipoprotein transport
|
GO:0042953 |
7 |
0.019
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.018
|
|
|
|
formation of radial glial scaffolds
|
GO:0021943 |
4 |
0.018
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.018
|
|
|
|
fatty acid biosynthetic process
|
GO:0006633 |
41 |
0.018
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.018
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.018
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.018
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.018
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.018
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.018
|
Worm |
|
|
protein processing
|
GO:0016485 |
163 |
0.018
|
|
|
|
positive regulation of sequestering of triglyceride
|
GO:0010890 |
4 |
0.018
|
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.018
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter in response to acidic ph
|
GO:0061402 |
2 |
0.018
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.018
|
|